Cargando…

Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case

Our objective was to gain insight in the calculation and interpretation of population health metrics that inform disease prevention. Using as model environmental exposure to lead (ELE), a global pollutant, we assessed population health metrics derived from the Third National Health and Nutrition Exa...

Descripción completa

Detalles Bibliográficos
Autores principales: Staessen, Jan A., Thijs, Lutgarde, Yang, Wen-Yi, Yu, Cai-Guo, Wei, Fang-Fei, Roels, Harry A., Nawrot, Tim S., Zhang, Zhen-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott, Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032208/
https://www.ncbi.nlm.nih.gov/pubmed/32008462
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14217
_version_ 1783676187535474688
author Staessen, Jan A.
Thijs, Lutgarde
Yang, Wen-Yi
Yu, Cai-Guo
Wei, Fang-Fei
Roels, Harry A.
Nawrot, Tim S.
Zhang, Zhen-Yu
author_facet Staessen, Jan A.
Thijs, Lutgarde
Yang, Wen-Yi
Yu, Cai-Guo
Wei, Fang-Fei
Roels, Harry A.
Nawrot, Tim S.
Zhang, Zhen-Yu
author_sort Staessen, Jan A.
collection PubMed
description Our objective was to gain insight in the calculation and interpretation of population health metrics that inform disease prevention. Using as model environmental exposure to lead (ELE), a global pollutant, we assessed population health metrics derived from the Third National Health and Nutrition Examination Survey (1988 to 1994), the GBD (Global Burden of Disease Study 2010), and the Organization for Economic Co-operation and Development. In the National Health and Nutrition Examination Survey, the hazard ratio relating mortality over 19.3 years of follow-up to a blood lead increase at baseline from 1.0 to 6.7 µg/dL (10th–90th percentile interval) was 1.37 (95% CI, 1.17–1.60). The population-attributable fraction of blood lead was 18.0% (10.9%–26.1%). The number of preventable ELE-related deaths in the United States would be 412 000 per year (250 000–598 000). In GBD 2010, deaths and disability-adjusted life-years globally lost due to ELE were 0.67 million (0.58–0.78 million) and 0.56% (0.47%–0.66%), respectively. According to the 2017 Organization for Economic Co-operation and Development statistics, ELE-related welfare costs were $1 676 224 million worldwide. Extrapolations from the foregoing metrics assumed causality and reversibility of the association between mortality and blood lead, which at present-day ELE levels in developed nations is not established. Other issues limiting the interpretation of ELE-related population health metrics are the inflation of relative risk based on outdated blood lead levels, not differentiating relative from absolute risk, clustering of risk factors and exposures within individuals, residual confounding, and disregarding noncardiovascular disease and immigration in national ELE-associated welfare estimates. In conclusion, this review highlights the importance of critical thinking in translating population health metrics into cost-effective preventive strategies.
format Online
Article
Text
id pubmed-8032208
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott, Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80322082021-04-09 Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case Staessen, Jan A. Thijs, Lutgarde Yang, Wen-Yi Yu, Cai-Guo Wei, Fang-Fei Roels, Harry A. Nawrot, Tim S. Zhang, Zhen-Yu Hypertension Reviews Our objective was to gain insight in the calculation and interpretation of population health metrics that inform disease prevention. Using as model environmental exposure to lead (ELE), a global pollutant, we assessed population health metrics derived from the Third National Health and Nutrition Examination Survey (1988 to 1994), the GBD (Global Burden of Disease Study 2010), and the Organization for Economic Co-operation and Development. In the National Health and Nutrition Examination Survey, the hazard ratio relating mortality over 19.3 years of follow-up to a blood lead increase at baseline from 1.0 to 6.7 µg/dL (10th–90th percentile interval) was 1.37 (95% CI, 1.17–1.60). The population-attributable fraction of blood lead was 18.0% (10.9%–26.1%). The number of preventable ELE-related deaths in the United States would be 412 000 per year (250 000–598 000). In GBD 2010, deaths and disability-adjusted life-years globally lost due to ELE were 0.67 million (0.58–0.78 million) and 0.56% (0.47%–0.66%), respectively. According to the 2017 Organization for Economic Co-operation and Development statistics, ELE-related welfare costs were $1 676 224 million worldwide. Extrapolations from the foregoing metrics assumed causality and reversibility of the association between mortality and blood lead, which at present-day ELE levels in developed nations is not established. Other issues limiting the interpretation of ELE-related population health metrics are the inflation of relative risk based on outdated blood lead levels, not differentiating relative from absolute risk, clustering of risk factors and exposures within individuals, residual confounding, and disregarding noncardiovascular disease and immigration in national ELE-associated welfare estimates. In conclusion, this review highlights the importance of critical thinking in translating population health metrics into cost-effective preventive strategies. Lippincott, Williams & Wilkins 2020-03 2020-02-03 /pmc/articles/PMC8032208/ /pubmed/32008462 http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14217 Text en © 2020 The Authors. https://creativecommons.org/licenses/by-nc-nd/4.0/Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Reviews
Staessen, Jan A.
Thijs, Lutgarde
Yang, Wen-Yi
Yu, Cai-Guo
Wei, Fang-Fei
Roels, Harry A.
Nawrot, Tim S.
Zhang, Zhen-Yu
Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title_full Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title_fullStr Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title_full_unstemmed Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title_short Interpretation of Population Health Metrics: Environmental Lead Exposure as Exemplary Case
title_sort interpretation of population health metrics: environmental lead exposure as exemplary case
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032208/
https://www.ncbi.nlm.nih.gov/pubmed/32008462
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14217
work_keys_str_mv AT staessenjana interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT thijslutgarde interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT yangwenyi interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT yucaiguo interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT weifangfei interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT roelsharrya interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT nawrottims interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase
AT zhangzhenyu interpretationofpopulationhealthmetricsenvironmentalleadexposureasexemplarycase